In Nigeria, the national vaccination campaign against mpox, a virus which has already infected 103 people in the country but has not killed anyone, began Monday October 21. Nigeria, with its 200 million inhabitants, is taking no risks and wants to act quickly to avoid an epidemic outbreak.
1 min
With only 9,000 doses available – after donating 1,000 to the Rwanda –, the Nigerian authorities are banking on a targeted strategy. Thus, vaccination against mpox will primarily concern the States of Nigeria the most affected like Cross River, Bayelsa and Akwa Ibom in the south, as well as Enugu State in the southeast.
Frontline healthcare workers, immunocompromised people, as well as contact cases will be given priority. Children aged five and over are also targeted by this campaign.
There are logistical challenges regarding road access, distances and supply chain. But thanks to our many recent and successful vaccine introduction experiences, we have built the necessary infrastructure and systems.
Dr Muyi Aina, Executive Director of the National Primary Health Care Development Agency
The vaccine, called Jynneos, offered by the United Statesis administered in two doses 28 days apart. Although this treatment is not manufactured in Nigeria, the government eventually plans to produce its own vaccines, although the disease is not an immediate priority.
Nigeria is not only fighting against mpox. The country must face measles, cholera and malaria. These diseases continue to place a heavy burden on the health system. Moreover, a new vaccination campaign against malaria was launched last week.
Also readMpox in the DRC: “We call on the entire African population concerned to be vaccinated”